跳至主要内容
临床试验/CTRI/2024/07/070631
CTRI/2024/07/070631尚未招募3 期

Evaluation of Hepatoprotective Activity of Bilwadi Agada in Alcoholic Liver Diseases A Clinical study

Sanjeevini Ayurveda Medical College and Hospital1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年8月1日最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
30
试验地点
1
主要终点
A comparative study will be done on 30 samples to evaluate the effect of Bilwadi Agada and Liv 52 in alcoholic liver diseases

研究概览

简要总结

In our clinical research work trial drug is bilwaadi agada in alcoholic liver diseases. The study will be conducted on 30 patients on the basis of IPD OPD medical camp patients. Investigations like CBC LFT USG will be conducted before and after the treatment. Later Bilwaadi agada will be given for 3 months observation for 3 months and total trial period is 1 year. The study aims to observe the efficacy of Bilwaadi agada on Alcholic liver diseases.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
30.00 Year(s) 至 60.00 Year(s)(—)
性别
Male

入选标准

  • Patient having history of Chronic alcoholism and Jaundice Serum Bilirubin in range of 2 to 3 mg/dl Patient within the age group 30 to 60years Male patients will be selected for the study.

排除标准

  • Patients with complications of Liver disorders – Cirrhosis of liver Systemic disorders If HBsAg positive and Hepitits A positive.

结局指标

主要结局

A comparative study will be done on 30 samples to evaluate the effect of Bilwadi Agada and Liv 52 in alcoholic liver diseases

时间窗: one year

次要结局

  • the comparative effect of bilwadi agada & Liv 52 will be assessed based on CBC LFT USG parameters(one year)

研究者

申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

DrAnjana L Siddapur

SANJEEVINI AYURVEDA MEDICAL COLLEGE AND HOSPITAL

研究点 (1)

Loading locations...

相似试验